← Back to opportunities

Adult ADHD assessments and treatment across NES (Oldham, Bury and Rochdale)

NHS Greater Manchester Integrated Care Board

Buyer Contact Info

Buyer Name: NHS Greater Manchester Integrated Care Board

Buyer Address: Manchester, UKD3, United Kingdom

Contact Email: nhsgm.procurement@nhs.net

Status
complete
Procedure
limited
Value
1146000.0 GBP
Published
27 Mar 2025, 16:27
Deadline
n/a
Contract Start
n/a
Contract End
n/a
Category
services
CPV
85121270 - Psychiatrist or psychologist services
Region
n/a
Awarded To
Optimise Healthcare Group
Official Source
Open Find a Tender

Description

A Provider Selection Regime (PSR) Urgent Award using Regulation 14 has been made for the provision of a limited number of neurodevelopmental assessments [autism & ASD] and for medication initiation, titration and medication reviews for adults with ADHD and requiring medication in Bury, Rochdale and Oldham.

Linked Documents

No linked documents found for this notice.

Opportunity Context

Lots

Lot Description: An urgent award is required to enable timely assessment to those deemed to require this and to maintain continuity of care for the patients currently in titration or under shared care. There is a high clinical risk to patients who require ongoing medication reviews and assessments in the event of any disruption in treatment. Patients can only be initiated on ADHD medication by a specialist provider and can only be prescribed ADHD medication in primary care under shared care arrangements with a specialist provider. This is because the medications are classed as AMBER drugs under the GMMMG Formulary. Patients on these drugs are required to have routine medication reviews by the specialist service to maintain safe prescribing. This contract is for 12 months from 1st April 2025 - 31st March 2026. The maximum contract value will be £1,146,000. Award decision-makers: Corporate Director of Finance - Commissioning & Financial Assurance and the Executive Committee on behalf on NHS Greater Manchester Integrated Care Board. No conflicts or potential conflicts of interest of the individuals making the decision identified. The procurement falls outside the scope of application of the regulations.

Lot 1 Status: cancelled

Lot 1 Has Options: No

Raw Notice JSON

Expand raw payload
{
  "awards": [
    {
      "id": "011636-2025-1",
      "relatedLots": [
        "1"
      ],
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-142154",
          "name": "Optimise Healthcare Group"
        }
      ]
    }
  ],
  "bids": {
    "statistics": [
      {
        "id": "2",
        "measure": "bids",
        "relatedLot": "1",
        "value": 1
      }
    ]
  },
  "buyer": {
    "id": "GB-FTS-121716",
    "name": "NHS Greater Manchester Integrated Care Board"
  },
  "contracts": [
    {
      "awardID": "011636-2025-1",
      "dateSigned": "2025-03-14T00:00:00Z",
      "id": "011636-2025-1",
      "status": "active",
      "value": {
        "amount": 1146000,
        "currency": "GBP"
      }
    }
  ],
  "date": "2025-03-27T16:27:37Z",
  "id": "011636-2025",
  "initiationType": "tender",
  "language": "en",
  "ocid": "ocds-h6vhtk-04f9b8",
  "parties": [
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "Manchester",
        "region": "UKD3"
      },
      "contactPoint": {
        "email": "nhsgm.procurement@nhs.net"
      },
      "details": {
        "classifications": [
          {
            "description": "Body governed by public law",
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE"
          },
          {
            "description": "Health",
            "id": "07",
            "scheme": "COFOG"
          }
        ],
        "url": "https://gmintegratedcare.org.uk/"
      },
      "id": "GB-FTS-121716",
      "identifier": {
        "legalName": "NHS Greater Manchester Integrated Care Board",
        "noIdentifierRationale": "notOnAnyRegister"
      },
      "name": "NHS Greater Manchester Integrated Care Board",
      "roles": [
        "buyer"
      ]
    },
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "Warrington",
        "region": "UKD3"
      },
      "contactPoint": {
        "email": "nhsgm.procurement@nhs.net"
      },
      "details": {
        "scale": "large",
        "url": "https://gmintegratedcare.org.uk/"
      },
      "id": "GB-FTS-142154",
      "identifier": {
        "legalName": "Optimise Healthcare Group",
        "noIdentifierRationale": "notOnAnyRegister"
      },
      "name": "Optimise Healthcare Group",
      "roles": [
        "supplier"
      ]
    },
    {
      "address": {
        "countryName": "United Kingdom",
        "locality": "Manchester"
      },
      "id": "GB-FTS-121716",
      "identifier": {
        "legalName": "NHS Greater Manchester Integrated Care Board"
      },
      "name": "NHS Greater Manchester Integrated Care Board",
      "roles": [
        "reviewBody"
      ]
    }
  ],
  "tag": [
    "award",
    "contract"
  ],
  "tender": {
    "classification": {
      "description": "Psychiatrist or psychologist services",
      "id": "85121270",
      "scheme": "CPV"
    },
    "description": "A Provider Selection Regime (PSR) Urgent Award using Regulation 14 has been made for the provision of a limited number of neurodevelopmental assessments [autism \u0026 ASD] and for medication initiation, titration and medication reviews for adults with ADHD and requiring medication in Bury, Rochdale and Oldham.",
    "id": "ocds-h6vhtk-04f9b8",
    "items": [
      {
        "deliveryAddresses": [
          {
            "region": "UKD"
          }
        ],
        "id": "1",
        "relatedLot": "1"
      }
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "lots": [
      {
        "awardCriteria": {
          "criteria": [
            {
              "type": "price"
            }
          ]
        },
        "description": "An urgent award is required to enable timely assessment to those deemed to require this and to maintain continuity of care for the patients currently in titration or under shared care. There is a high clinical risk to patients who require ongoing medication reviews and assessments in the event of any disruption in treatment.\nPatients can only be initiated on ADHD medication by a specialist provider and can only be prescribed ADHD medication in primary care under shared care arrangements with a specialist provider. This is because the medications are classed as AMBER drugs under the GMMMG Formulary. Patients on these drugs are required to have routine medication reviews by the specialist service to maintain safe prescribing.\nThis contract is for 12 months from 1st April 2025 - 31st March 2026.\nThe maximum contract value will be \u00a31,146,000.\nAward decision-makers: Corporate Director of Finance - Commissioning \u0026 Financial\nAssurance and the Executive Committee on behalf on NHS Greater Manchester Integrated Care Board.\nNo conflicts or potential conflicts of interest of the individuals making the decision identified.\nThe procurement falls outside the scope of application of the regulations.",
        "hasOptions": false,
        "id": "1",
        "status": "cancelled"
      }
    ],
    "mainProcurementCategory": "services",
    "procurementMethod": "limited",
    "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
    "procurementMethodRationale": "The procurement falls outside the scope of application of the regulations as PSR",
    "procurementMethodRationaleClassifications": [
      {
        "description": "The procurement falls outside the scope of application of the directive",
        "id": "D_OUTSIDE_SCOPE",
        "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL"
      }
    ],
    "status": "complete",
    "title": "Adult ADHD assessments and treatment across NES (Oldham, Bury and Rochdale)"
  }
}